These experiments were then used to guide the ASO treatment study in SOD1*G93A ALS mice to determine the effect of Atp1a2 knockdown on disease onset and survival outcome (Fig 1B). This evidence concerns the gene ATP1A2 and amyotrophic lateral sclerosis.